UPDATED May 04, 2024
Companies which grew earnings more than 50% in the last year.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
A071200 | ₩5,230.00 | 2.1% | -1.5% | ₩127.5b | n/a | PE6.7x | n/a | n/a | ||
PODD | US$174.43 | 5.0% | -46.9% | US$12.2b | US$236.47 | PE59.2x | E17.5% | n/a | ||
PTRK | kr14.10 | -2.8% | -9.6% | kr229.3m | kr34.95 | PE6.1x | S19.6% | n/a | ||
HAEK | €17.40 | 2.4% | n/a | €91.0m | n/a | PE9.5x | E5.8% | 6.9% | ||
ATT | kr43.45 | 2.7% | 20.7% | kr6.9b | kr52.50 | PE16.8x | E21.9% | 2.3% | ||
531099 | ₹9.99 | 0% | 92.5% | ₹54.6m | n/a | PE34.7x | n/a | n/a | ||
3390 | HK$4.02 | -0.2% | -16.3% | HK$3.2b | n/a | PE10.8x | n/a | 1.7% | ||
EMC | zł11.00 | 0% | 18.9% | zł462.1m | n/a | PE38.7x | n/a | n/a | ||
THC | US$120.28 | 25.1% | 73.4% | US$11.7b | US$128.33 | PE4.5x | E-35.9% | n/a | ||
9265 | JP¥2,686.00 | 1.6% | 21.5% | JP¥6.8b | n/a | PE10.3x | n/a | 2.0% | ||
3184 | NT$12.10 | 0.8% | -21.9% | NT$971.3m | n/a | PE25.5x | n/a | 0% | ||
A059210 | ₩4,285.00 | 0.9% | 91.3% | ₩98.0b | n/a | PE9.5x | n/a | 0.5% | ||
ONCO3 | R$7.27 | -1.0% | -21.1% | R$3.7b | R$15.89 | PE16.5x | E35.1% | n/a | ||
CRAD B | kr37.80 | -2.3% | 16.0% | kr1.3b | kr58.00 | PE35.8x | E34.9% | n/a | ||
7782 | JP¥494.00 | 0.8% | -15.1% | JP¥3.1b | n/a | PE10.6x | n/a | 2.0% | ||
VHI | CA$6.38 | 2.1% | 139.8% | CA$323.4m | CA$7.71 | PE71.1x | E41.0% | n/a | ||
XVIVO | kr378.00 | 1.3% | 23.5% | kr11.9b | kr408.00 | PE118.6x | E36.1% | n/a | ||
MONOPHARMA | ₹46.00 | 3.5% | n/a | ₹812.8m | n/a | PE36.7x | n/a | n/a | ||
SFT | лв5.75 | 1.8% | -0.9% | лв197.1m | n/a | PE6.6x | n/a | 0% | ||
CARE | kr29.00 | 7.4% | 81.3% | kr705.5m | kr28.50 | PE15.4x | E16.8% | n/a | ||
SPI | UK£2.48 | 0.6% | 4.9% | UK£1.0b | UK£3.07 | PE36.7x | E24.8% | 0.8% | ||
A261200 | ₩9,190.00 | -1.3% | -15.9% | ₩140.4b | n/a | PE36.6x | n/a | n/a | ||
6931 | NT$106.00 | 1.9% | 88.3% | NT$5.9b | n/a | PE151x | n/a | n/a | ||
BIOBV | €2.00 | -1.0% | 7.5% | €30.3m | €2.40 | PE16.4x | E8.9% | 0% |